- Report
- April 2026
- 150 Pages
Malaysia
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Mexico
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Netherlands
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
South Africa
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
South Korea
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Spain
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Thailand
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
Turkey
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2026
- 150 Pages
United Kingdom
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 182 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 182 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 174 Pages
Germany
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 173 Pages
Canada
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 175 Pages
India
From €4346EUR$4,850USD£3,722GBP
- Report
- January 2026
- 150 Pages
India
From €4346EUR$4,850USD£3,722GBP
- Report
- January 2026
- 150 Pages
Japan
From €4346EUR$4,850USD£3,722GBP
- Report
- October 2025
- 150 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- September 2025
- 150 Pages
Canada
From €4346EUR$4,850USD£3,722GBP

The Biomolecules market is a subset of the biotechnology industry that focuses on the production and use of biomolecules. These molecules are typically proteins, nucleic acids, carbohydrates, and lipids, and are used in a variety of applications, such as drug discovery, diagnostics, and therapeutics. The market is driven by advances in biotechnology, which have enabled the development of new and improved biomolecules. Additionally, the increasing demand for personalized medicine and the development of new technologies, such as gene editing, are expected to drive the growth of the market.
The Biomolecules market is highly competitive, with a number of large companies, such as Amgen, Merck, and Novartis, as well as smaller companies, such as Genentech and Biogen, competing for market share. Additionally, there are a number of start-ups and research institutions that are developing new technologies and products. Show Less Read more